PALI- Palisade Bio, Inc.

Name: Palisade Bio, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Palisade Bio, Inc. (PALI) has 5 insiders with recent SEC Form 4 filings, including 15 buys and 0 sells. PALI is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
CEO	Finley John David	9.18M	$18.27M	-
Other	Jones Mitchell Lawrence	7.67M	$15.25M	-
Dir	Chuang Emil	510.7K	$1.02M	-
Dir	Wei Binxian	510.7K	$1.02M	-
Dir	Williams Donald Allen	10.7K	$21.3K	-

Activity

Buys and sells only

Transactions

10 filings · page 3

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Sep 10, 2021	Trenschel Robert J.	Director	Buy	14,999	$2.82	$42,297.12	+52.6%	-34.0%	-95.1%
Aug 27, 2021	Finley John David	Chief Financial Officer	Buy	10,000	$2.65	$26,468.00	+156.4%	-8.7%	-92.7%
May 17, 2017	Daly Richard J	Chief Executive Officer	Buy	7,500	$4.00	$30,000.00	+47.4%	-	-
Mar 24, 2017	Lloyd Jones Jonathan Brian	Chief Financial Officer	Buy	5,455	$5.50	$30,002.50	+226.9%	-	-
Feb 24, 2017	Daly Richard J	Chief Executive Officer	Buy	2,591	$3.86	$10,001.26	+19.6%	-	-
Jan 25, 2017	Daly Richard J	Chief Executive Officer	Buy	2,841	$3.52	$10,000.32	+27.4%	-	-
Dec 23, 2016	Daly Richard J	Chief Executive Officer	Buy	32,259	$0.31	$10,000.29	+31.4%	-	-
Nov 25, 2016	Daly Richard J	Chief Executive Officer	Buy	35,715	$0.28	$10,000.20	+53.3%	-	-
Oct 25, 2016	Daly Richard J	Chief Executive Officer	Buy	35,715	$0.28	$10,000.20	+114.3%	-	-
Sep 23, 2016	Lloyd Jones Jonathan Brian	Chief Financial Officer	Buy	31,250	$0.32	$10,000.00	New	-	-

← PrevPage 3Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC